Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Oral Investigations
Published in: Clinical Oral Investigations 1/2015

01-01-2015 | Original Article

Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease

Authors: Rashi Chaturvedi, Mili Gupta, Ashish Jain, Tarun Das, Savita Prashar

Published in: Clinical Oral Investigations | Issue 1/2015

Login to get access

Abstract

Objectives

Periodontitis involves a complex interplay of micro-organisms and host immune response via numerous mediator molecules playing strategic roles in its pathogenesis. Soluble CD40L (sCD40L) is one such co-stimulatory molecule which is essential for T-helper cell activation and is a well-known risk indicator of cardiovascular diseases. The levels of this marker in crevicular fluid of patients of chronic periodontitis have been explored in the present study for the first time along with an analysis of its association with levels in serum in otherwise systemically healthy patients.

Methodology

Sixty patients 20 healthy and 40 of chronic periodontitis (18 moderate and 22 severe) participated in the study. Patients of the diseased group underwent non-surgical periodontal therapy. Clinical evaluation and collection of gingival crevicular fluid (GCF) and serum samples was done at baseline, and 6 weeks after phase I periodontal therapy. sCD40L levels were quantified in the fluids using ELISA.

Results

Levels of sCD40L in GCF were significantly higher in the diseased group (p ≤ 0.001) and strongly correlated not only with increasing severity of disease but also with levels in serum. In post-treatment, the levels decreased significantly in both the biological fluids (p ≤ 0.001).

Conclusions

The present study brings to light the role of sCD40L as a novel marker in mediating periodontal destruction and disease progression. Evaluation of local treatment outcomes seems promising in minimizing these effects.

Clinical relevance

Positive association of its local levels with those in serum further implicates the possibility of widespread systemic effects of this infection.
Literature
1.
Page RC, Kornman KS (1997) The pathogenesis of human periodontitis: an introduction. Periodontol 14:9–11CrossRef
2.
3.
Azuma M (2006) Fundamental mechanisms of host immune responses to infection. J Periodont Res 41:361–373PubMedCrossRef
4.
Zhang X, Teng YTA (2003) The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 14:237–252CrossRef
5.
Yamazaki K, Yoshie H, Seymour GJ (2003) T cell regulation of the immune response to infection in periodontal diseases. Histol Histopathol 18:889–896PubMed
6.
Mathur A, Michalowicz BS (1997) Cell-mediated immune system regulation in periodontal diseases. Crit Rev Oral Biol Med 8:76–89PubMedCrossRef
7.
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357PubMed
8.
Gately MK, Renzetti LM, Magram J et al (1998) The interleukin-12/interleukin-12- receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16:495–521PubMedCrossRef
9.
Grewal IS, Flavell RA (1996) A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 17:410–414PubMedCrossRef
10.
Lenschow DL, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233–258PubMedCrossRef
11.
12.
13.
Van Kooten C, Banchereau J (1996) CD 40- CD 40 ligand: a multifunctional receptor—ligand pair. Adv Immunol 61:1–77PubMedCrossRef
14.
Grewal IS, Flavell RA (1998) CD40 and CD 154 in cell mediated immunity. Annu Rev Immunol 16:111–135PubMedCrossRef
15.
16.
17.
Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P (1997) Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes : a role for CD40 signalling in plaque rupture ? Circ Res 81:448–454PubMedCrossRef
18.
19.
Zhou L, Stordeur P, de Lavareille A, Theilman K, Capel P, Goldman M et al (1998) CD40 engagement on endothelial cells promotes tissue factor dependent procoagulant activity. Thromb Haemostat 79:1025–1028
20.
Paquette DW, Brodala N, Nichols TC (2007) Cardiovascular disease, inflammation, and periodontal infection. Periodontology 44:113–126CrossRef
21.
Herzberg MC, Weyer MW (1998) Dental plaque, platelets and cardiovascular disease. Ann Periodontol 3:151–160PubMedCrossRef
22.
Lockhart PB, Bolger AF, Papapanou PN et al (2012) Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? A scientific statement from the American Heart Association. Circulation 125:2520–2544PubMedCrossRef
23.
Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154:830–837PubMedCrossRef
24.
Beck JD, Garcia R, Heiss G, Vokonas P, Offenbacher S (1996) Periodontal disease and cardiovascular disease. J Periodontol 67:1123–1137PubMedCrossRef
25.
Matilla KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL (1993) Dental infections and coronary atherosclerosis. Atherosclerosis 103:205–211CrossRef
26.
Aukrust P, Muller F, Ueland T et al (1999) Enhanced levels of soluble and membrane bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614–620PubMedCrossRef
27.
Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM et al (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 349:1104–1111CrossRef
28.
Balla J, Magyar MT, Bereczki D, Valikovics A, Nagy E, Barna E et al (2006) Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis Markers 22:133–140PubMedCentralPubMedCrossRef
29.
Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266–2268PubMedCrossRef
30.
Papapanagiotou D, Nicu EA, Bizzarro S et al (2009) Periodontitis is associated with platelet activation. Atherosclerosis 202:605–611PubMedCrossRef
31.
Marcaccini AM, Meschiari CA, Sorgi CA et al (2009) Circulating interleukin- 6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 80:594–602PubMedCrossRef
32.
Dongari- Bagtzoglou AI, Warren WD, Berton MT, Ebersole JL (1997) CD40 expression by gingival fibroblasts: correlation of phenotype with function. Int Immunol 9:1233–1241PubMedCrossRef
33.
Alhashimi N, Frithiof L, Brudvik P, Bakhiet M (2004) CD40–CD40L expression during orthodontic tooth movement in rats. Angle Orthod 74:100–105PubMed
34.
Sempowski GD, Chess PR, Moretti AJ, Padilla J, Phipps RP, Blieden TM (1997) CD40 mediated activation of gingival and PDL fibroblast. J Periodontol 68:284–292PubMedCrossRef
35.
Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S (2003) Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 31:167–180CrossRef
36.
Loe SJ (1963) Periodontal disease in pregnancy. I. prevalence and severity. Acta Odontol Scand 21:533–551PubMedCrossRef
37.
38.
Page RC, Eke PI (2007) Case definitions for use in population-based surveillance of periodontitis. J Periodontol 78:1387–1399PubMedCrossRef
39.
Harris EF, Smith RN (2009) Accounting for measurement error: a critical but often overlooked process. Archives of Oral Biol 54s:s107–s117CrossRef
40.
Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86:306–319PubMedCrossRef
41.
Wassenaar A, Verschoor T, Kievits F, Den Hartog MT, Kapsenberg ML, Everts V, Snijders A (1999) CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin Exp Immunol 115:161–167PubMedCentralPubMedCrossRef
42.
Reyes L, Herrera D, Kozarov E, Rold_an S, Progulske-Fox A (2013) Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Periodontol 84:S30–S50PubMedCrossRef
43.
Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE (2003) Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71(10):6012–6018PubMedCentralPubMedCrossRef
44.
Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109(21 Suppl 1):II2–II10PubMed
45.
Bizzarro S, van der Velden U, ten Heggeler JMAG et al (2007) Periodontitis is characterized by elevated PAI-1 activity. J Clin Periodontol 34:574–580PubMedCrossRef
46.
Gupta M, Chaturvedi R, Jain A (2013) Role of monocyte chemoattractant protein-1(MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine 61(3):892–897PubMedCrossRef
47.
Wakai K, Kawamura T, Umemura O et al (1999) Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 26:664–672PubMedCrossRef
48.
Christan C, Dietrich T, Hagewald S, Kage A, Bernimoulin JP (2002) White blood cell count in generalized aggressive periodontitis after nonsurgical therapy. J Clin Periodontol 29:201–206PubMedCrossRef
49.
Andre P, Nannizzi-Alaimo L, Prasad DK, Phillips DR (2002) Platelet derived CD40L: the switch hitting player of cardiovascular disease. Circulation 106:896–899PubMedCrossRef
50.
Schenkein HA, Loos BG (2013) Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol 84:S51–S69PubMedCrossRef
51.
D’Aiuto F, Orlandi M, Gunsolley JC (2013) Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Periodontol 84:S85–S105PubMedCrossRef
52.
Tonetti MS, D’Aiuto F, Nibali L et al (2007) Treatment of periodontitis and endothelial function. N Engl J Med 356:911–920PubMedCrossRef
Metadata
Title
Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease
Authors
Rashi Chaturvedi
Mili Gupta
Ashish Jain
Tarun Das
Savita Prashar
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 1/2015
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-014-1216-3

Other articles of this Issue 1/2015

Clinical Oral Investigations 1/2015 Go to the issue

Original Article

Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors

Original Article

TEGDMA and filler particles from dental composites additively attenuate LPS-induced cytokine release from the macrophage cell line RAW 264.7

Original Article

The effect of different pretreatment methods of PMMA-based crowns on the long-term tensile bond strength to dentin abutments

Original Article

Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults

Original Article

Synchrotron light-based μCT to analyse the presence of dentinal microcracks post-rotary and reciprocating NiTi instrumentation

Original Article

Effect of tooth brush abrasion and thermo-mechanical loading on direct and indirect veneer restorations